Australia markets closed

Connect Biopharma Holdings Limited (CNTB)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.3400-0.0100 (-0.74%)
At close: 04:00PM EDT
1.3300 -0.01 (-0.75%)
After hours: 07:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 73.84M
Enterprise value -44.35M
Trailing P/E N/A
Forward P/E 0.82
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.73
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.76

Trading information

Stock price history

Beta (5Y monthly) -0.60
52-week change 327.62%
S&P500 52-week change 322.36%
52-week high 32.8400
52-week low 30.5350
50-day moving average 31.4429
200-day moving average 31.1631

Share statistics

Avg vol (3-month) 3162.32k
Avg vol (10-day) 361.48k
Shares outstanding 555.1M
Implied shares outstanding 655.51M
Float 816.05M
% held by insiders 141.26%
% held by institutions 144.01%
Shares short (15 Apr 2024) 483.14k
Short ratio (15 Apr 2024) 40.38
Short % of float (15 Apr 2024) 40.27%
Short % of shares outstanding (15 Apr 2024) 40.15%
Shares short (prior month 15 Mar 2024) 4107.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.07%
Return on equity (ttm)-46.03%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -64.23M
Net income avi to common (ttm)-59.5M
Diluted EPS (ttm)-1.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)118.7M
Total cash per share (mrq)2.15
Total debt (mrq)465k
Total debt/equity (mrq)0.46%
Current ratio (mrq)4.99
Book value per share (mrq)1.83

Cash flow statement

Operating cash flow (ttm)-47.93M
Levered free cash flow (ttm)-27.07M